---
figid: PMC12066790__41392_2025_2197_Fig5_HTML
figtitle: Oncogenic mechanisms of EBV in gastric cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12066790
filename: 41392_2025_2197_Fig5_HTML.jpg
figlink: /pmc/articles/PMC12066790/figure/F5/
number: F5
caption: 'Oncogenic mechanisms of EBV in gastric cancer. a EBV induces genomic instability
  by promoting DNA methylation and inhibiting P53-mediated DNA repair. b EBV-encoded
  proteins disrupt the TGF-β1/Smad pathway, activate NF-κB and STAT3 signaling pathways,
  upregulate oncogene expression, and promote the degradation of tumor suppressor
  proteins, resulting in malignant cell proliferation. c EBV promotes immune evasion
  by impairing antigen presentation, increasing PD-L1 expression, and disrupting the
  function of CTLs and NK cells while increasing Tregs and TAMs in the TME. d EBV
  facilitates angiogenesis via KHSRP/VHL/HIF-1α/VEGFA and PI3K/AKT/mTOR/HIF-1α pathways
  and enhances extracellular matrix remodeling, aiding metastasis. Red text: EBV components;
  Black text: host cell components; Direct oncogenesis: a, b; Indirect oncogenesis:
  c, d. This figure was created with BioRender.com'
papertitle: 'Viral oncogenesis in cancer: from mechanisms to therapeutics'
reftext: Qing Xiao, et al. Signal Transduct Target Ther. 2025;10(NA).
year: '2025'
doi: 10.1038/s41392-025-02197-9
journal_title: Signal Transduction and Targeted Therapy
journal_nlm_ta: Signal Transduct Target Ther
publisher_name: Nature Publishing Group
keywords: Tumour virus infections | Oncogenes
automl_pathway: 0.9633274
figid_alias: PMC12066790__F5
figtype: Figure
redirect_from: /figures/PMC12066790__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12066790__41392_2025_2197_Fig5_HTML.html
  '@type': Dataset
  description: 'Oncogenic mechanisms of EBV in gastric cancer. a EBV induces genomic
    instability by promoting DNA methylation and inhibiting P53-mediated DNA repair.
    b EBV-encoded proteins disrupt the TGF-β1/Smad pathway, activate NF-κB and STAT3
    signaling pathways, upregulate oncogene expression, and promote the degradation
    of tumor suppressor proteins, resulting in malignant cell proliferation. c EBV
    promotes immune evasion by impairing antigen presentation, increasing PD-L1 expression,
    and disrupting the function of CTLs and NK cells while increasing Tregs and TAMs
    in the TME. d EBV facilitates angiogenesis via KHSRP/VHL/HIF-1α/VEGFA and PI3K/AKT/mTOR/HIF-1α
    pathways and enhances extracellular matrix remodeling, aiding metastasis. Red
    text: EBV components; Black text: host cell components; Direct oncogenesis: a,
    b; Indirect oncogenesis: c, d. This figure was created with BioRender.com'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DNMT1
  - CD8A
  - CD8B
  - STAT3
  - PDLIM7
  - THBS1
  - APBA1
  - RASSF1
  - CXXC4
  - APC
  - PROC
  - TP73
  - ARHGAP24
  - CDKN2A
  - H3P10
  - S100A9
  - CDK2AP2
  - SUB1
  - RPP14
  - LAMTOR2
  - SF3B6
  - H3P8
  - PTEN
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - KLKB1
  - RIPK4
  - TP53
  - TP63
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - MMUT
  - JAK2
  - PIK3CA
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - IGF1R
  - TGFB1
  - IGF1
  - GCNT3
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - LAG3
  - KLRK1
  - CD274
  - CCL22
  - PIAS3
  - ARL2BP
  - FOXP1
  - FOXP2
  - FOXP3
  - FOXP4
  - PBRM1
  - MMP9
  - MMP2
  - NFKB1
  - WTAP
  - TGFB2
  - TGFB3
  - E2F1
  - UBE2L3
  - DKK1
  - DAB2
  - BID
  - BAD
  - BBC3
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - STMN1
  - HIF1A
  - VEGFA
  - KHSRP
  - VHL
  - AKT1
  - AKT2
  - AKT3
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IHH
  - SNAI1
  - TIMP2
  - CDH1
  - FZR1
  - CTNNB1
  - Methyl group
  - cancer
---
